AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 24182692
Drug: Intralesional triamcinolone
RxNorm normalized name: Triamcinolone
DrugBank: Triamcinolone (DB00620)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intralesional triamcinolone (T) @40 mg/ml, 1.5 ml, injections every three weeks until complete flattening or eight sessions
Trial: 24182692
Drug: Intralesional verapamil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intralesional verapamil (V) @2.5 mg/ml, 1.5 ml, injections every three weeks until complete flattening or eight sessions
Trial: 17391154
Drug: Insulin detemir
RxNorm normalized name: Insulin Detemir
DrugBank: Insulin detemir (DB01307)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Insulin detemir (0.4, 0.8, 1.4 U/kg)
Trial: 17391154
Drug: Insulin glargine
RxNorm normalized name: Insulin Glargine
DrugBank: Insulin glargine (DB00047)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Insulin glargine (0.4, 0.8, 1.4 U/kg)
Trial: 17391154
Drug: NN344 and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NN344 and insulin detemir
Trial: 24725803
Drug: All insulin
RxNorm normalized name: Small Insulin Syringe 1cc 31g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: All insulin preparations
Trial: 12025879
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (received no special treatment)
Trial: 7621730
Drug: Aspiration of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspiration of insulin syringe during injection
Trial: 7621730
Drug: Non-aspiration technique
RxNorm normalized name: Tavist Non-Sedating
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-aspiration technique for insulin administration
Trial: 2883055
Drug: Pulsatile insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pulsatile insulin (0.85 mU X kg‐1 X min‐1 during 2 min followed by 8 min with no insulin)
Trial: 2883055
Drug: Continuous insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Continuous insulin (0.17 mU X kg‐1 X min‐1)
Trial: 2883055
Drug: Pulsatile insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pulsatile insulin
Trial: 26876240
Drug: Combined orbital
RxNorm normalized name: barbital
DrugBank: Barbital (DB01483)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined orbital radiotherapy and steroid pulse therapy (SRT group)
Trial: 26876240
Drug: Steroid pulse
RxNorm normalized name: dulse extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Steroid pulse therapy only (ST group)
Trial: 9240727
Drug: 800 mg
RxNorm normalized name: bran 800 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 800 mg clodronate tablet
Trial: 9240727
Drug: 400 mg
RxNorm normalized name: mesna 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 mg clodronate capsule
Trial: 2880804
Drug: ICI 118551,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ICI 118551, 50 mg t.i.d. orally
Trial: 10657404
Drug: Selfotel (1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Selfotel (1.5 mg/kg intravenous dose within 6 hours of stroke onset)
Trial: 26897029
Drug: BBaRTS intervention
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: BBaRTS intervention (children's storybooks with embedded BCTs, parenting skills, and oral health messages)
Trial: 21060724
Drug: 5-Loxin(®) 100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5-Loxin(®) 100 mg daily for 90 days
Trial: 21060724
Drug: Aflapin(®) 100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aflapin(®) 100 mg daily for 90 days
Trial: 15167206
Drug: Constant drinkers
RxNorm normalized name: constant albicans extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Constant drinkers consuming 0.1‐19.9 g alcohol per day
Trial: 15167206
Drug: Constant drinkers
RxNorm normalized name: constant albicans extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Constant drinkers consuming 20.0‐39.9 g alcohol per day
Trial: 15167206
Drug: Female constant
RxNorm normalized name: constant albicans extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Female constant drinkers consuming 0.1‐19.9 g daily alcohol
Trial: 9693202
Drug: Omeprazole 20
RxNorm normalized name: omeprazole 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole 20 mg b.i.d. + Amoxicillin 500 mg q.i.d. + Clarithromycin 400 mg b.i.d. (OAC)
Trial: 9693202
Drug: Omeprazole 20
RxNorm normalized name: omeprazole 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole 20 mg b.i.d. + Clarithromycin 400 mg b.i.d. (OC)
Trial: 8207292
Drug: SY5555 150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SY5555 150 mg x 3/day for 7 days
Trial: 8207292
Drug: SY5555 300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SY5555 300 mg x 3/day for 7 days
Trial: 8207292
Drug: SY5555 150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SY5555 150 mg x 3/day
Trial: 8207292
Drug: SY5555 300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SY5555 300 mg x 3/day
Trial: 8207292
Drug: SY5555 treatment
RxNorm normalized name: benzoyl peroxide
DrugBank: Benzoyl peroxide (DB09096)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: SY5555 treatment
Trial: 30292578
Drug: Hybrid closed-loop
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hybrid closed-loop therapy
Trial: 30292578
Drug: Sensor-augmented pump
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sensor-augmented pump therapy (Control)
Trial: 28939581
Drug: VZV vaccination
RxNorm normalized name: VZV immune globulin
DrugBank: Human varicella-zoster immune globulin (DB11621)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: VZV vaccination (live-attenuated VZVOka vaccine)
Trial: 21685235
Drug: Lapatinib (1500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lapatinib (1500 mg/d) for three weeks
Trial: 16487220
Drug: TDS-testosterone (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TDS-testosterone (50 mg)
Trial: 16487220
Drug: Androgel (1%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Androgel (1% topical testosterone gel)
Trial: 12066421
Drug: Fictitious medication
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fictitious medication with varying sample sizes (4, 6, 8, or 40 trials) and contingency (delta P = .20, .40, .60, or .80)
Trial: 10321913
Drug: 17beta-estradiol (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 17beta-estradiol (all doses)
Trial: 8621845
Drug: Nedocromil sodium
RxNorm normalized name: Nedocromil Sodium
DrugBank: Nedocromil (DB00716)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nedocromil sodium (NS), 4 mg inhaled, 4 times daily for 3 months
Trial: 8621845
Drug: Placebo, 4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo, 4 times daily for 3 months
Trial: 1774443
Drug: Parlodel LAR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Parlodel LAR (long-acting intramuscularly injectable depot preparation of bromocriptine)
Trial: 7048890
Drug: Fructose sweetened
RxNorm normalized name: Fructose
DrugBank: Fructose (DB04173)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Fructose sweetened cakes and ice creams
Trial: 7048890
Drug: Ice creams
RxNorm normalized name: Camphor Ice Topical Product
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ice creams
Trial: 7048890
Drug: Sucrose sweetened
RxNorm normalized name: Sucrose
DrugBank: Sucrose (DB02772)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sucrose sweetened cakes and ice creams
Trial: 30239596
Drug: Panfacial aesthetic
RxNorm normalized name: Gelato Anesthetic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Panfacial aesthetic treatment
Trial: 26088885
Drug: Overall treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Overall treatment (Lorazepam + 1st AED)
Trial: 26088885
Drug: Overall treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Overall treatment (with addition of 2nd AED)
Trial: 26088885
Drug: Overall treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Overall treatment (with addition of 3rd AED)
Trial: 17689931
Drug: Sham rTMS
RxNorm normalized name: BLACK BEAN ANTI HAIR LOSS SHAM POO SET KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sham rTMS (ineffective treatment)
Trial: 9146770
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg omeprazole once daily + 1000 mg amoxycillin b.d. (days 5-14)
Trial: 9146770
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg omeprazole b.d. + 1000 mg amoxycillin b.d. (days 5-14)
Trial: 9146770
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg omeprazole b.d. + 1000 mg amoxycillin b.d. (days 5-14)
Trial: 9146770
Drug: 60 mg
RxNorm normalized name: opium 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 60 mg omeprazole b.d. + 1000 mg amoxycillin b.d. (days 5-14)
Trial: 7711430
Drug: Recombinant interleukin-2
RxNorm normalized name: Recombinant interleukin-2 human
DrugBank: Aldesleukin (DB00041)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Recombinant interleukin-2 and interferon-alpha 2b (rIL-2 and IFN-alpha 2b) administered subcutaneously for 6 weeks (3 treatment cycles, each with 3 weeks of administration)
Trial: 3330985
Drug: Captopril (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Captopril (50 mg, twice daily; n = 7)
Trial: 19217154
Drug: Ustekinumab (90
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ustekinumab (90 mg or 63 mg) every week for 4 weeks (weeks 0-3)
Trial: 19217154
Drug: Ustekinumab (63
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ustekinumab (63 mg) at weeks 12 and 16
Trial: 19217154
Drug: Ustekinumab (90
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ustekinumab (90 mg or 63 mg)
Trial: 16708768
Drug: Gynostemma pentaphyllum
RxNorm normalized name: GYNOSTEMMA PENTAPHYLLUM TOP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gynostemma pentaphyllum (GP) extraction 80 mL for 4 months after 2 months of controlled diet
Trial: 16708768
Drug: Placebo capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo capsule for 4 months after 2 months of controlled diet
Trial: 15636412
Drug: Multicomponent treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multicomponent treatment intervention (MTI)
Trial: 11422765
Drug: Parenteral iron
RxNorm normalized name: Iron, parenteral preparations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Parenteral iron administration (iron dextran 100 mg at ten consecutive dialysis sessions)
Trial: 11422765
Drug: No parenteral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No parenteral iron administration
Trial: 8501147
Drug: 5 IU
RxNorm normalized name: Vitamin E 15 IU/0.3 ML Oral Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 IU GH (iv infusion)
Trial: 8501147
Drug: 5 IU
RxNorm normalized name: Vitamin E 15 IU/0.3 ML Oral Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 IU GH (im bolus injection)
Trial: 8501147
Drug: 48 IU
RxNorm normalized name: Acetylcarnitine/alpha Tocopherol/alpha Tocotrienol/Ascorbic Acid/beta Tocopherol/Betaine/Coenzyme Q10/Cyanocobalamin/delta Tocopherol/delta Tocotrienol/Docosahexaenoic Acid/Eicosapentaenoic Acid/Folic Acid/gamma Tocopherol/gamma Tocotrienol/Grape Seed Extract/Lecithin/Levocarnitine/Magnesium/Niacin/Olive Oil/Pyridoxine Hydrochloride/Selenomethionine/Taurine/Thioctic Acid 12.5 MG-30 IU-75 MCG-250 MG-3 IU-50 MG-30 MG-50 MCG-48 IU-125 MCG-60 MG-90 MG-0.5 MG-180 IU-1100 MCG-50 MG-50 MG-50 MG-100 MG-25 MG-215 MG-25 MG-50 MCG-25 MG-25 MG Oral Capsule, Liquid Filled
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 48 IU GH (iv infusion)
Trial: 8501147
Drug: 30 micrograms/h
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 micrograms/h GHRH (iv infusion)
Trial: 3125077
Drug: Enterococcus lactic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enterococcus lactic acid bacteria strain SF68 (two capsules three times daily)
Trial: 3125077
Drug: Lactulose (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lactulose (30 ml four times daily)
Trial: 26717867
Drug: Dual antiplatelet
RxNorm normalized name: Tums Dual Action
DrugBank: Alginic acid (DB13518)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dual antiplatelet therapy (DAPT) pre-operatively for CAS
Trial: 26717867
Drug: Dual antiplatelet
RxNorm normalized name: Tums Dual Action
DrugBank: Alginic acid (DB13518)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dual antiplatelet therapy (DAPT) post-operatively for CAS
Trial: 26717867
Drug: Dual antiplatelet
RxNorm normalized name: Tums Dual Action
DrugBank: Alginic acid (DB13518)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dual antiplatelet therapy (DAPT) pre-operatively for CEA
Trial: 26717867
Drug: Dual antiplatelet
RxNorm normalized name: Tums Dual Action
DrugBank: Alginic acid (DB13518)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dual antiplatelet therapy (DAPT) post-operatively for CEA
Trial: 26717867
Drug: Mono antiplatelet
RxNorm normalized name: tiotropium bromide mono
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mono antiplatelet therapy (MAPT) post-procedural
Trial: 26717867
Drug: Testing for
RxNorm normalized name: mumps skin test antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Testing for antiplatelet therapy resistance
Trial: 20919760
Drug: Treatment Advocacy
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment Advocacy Program (TAP)
Trial: 16313478
Drug: 1 mg
RxNorm normalized name: biotin 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg 17beta-oestradiol plus 1 mg DRSP
Trial: 16313478
Drug: 1 mg
RxNorm normalized name: biotin 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg 17beta-oestradiol plus 2 mg DRSP
Trial: 16313478
Drug: 1 mg
RxNorm normalized name: biotin 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg 17beta-oestradiol plus 3 mg DRSP
Trial: 12484506
Drug: ACE inhibitor
RxNorm normalized name: ACE INHIBITORS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ACE inhibitor plus spironolactone (25 mg) for 60 weeks
Trial: 12484506
Drug: ACE inhibitor
RxNorm normalized name: ACE INHIBITORS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ACE inhibitor alone for 60 weeks
Trial: 7590617
Drug: Dexamethasone 1
RxNorm normalized name: dexamethasone 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamethasone 1 mg given at 11:00 p.m. on on-call night
Trial: 7590617
Drug: Dexamethasone 1
RxNorm normalized name: dexamethasone 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamethasone 1 mg given at 11:00 p.m. on control night
Trial: 2075246
Drug: Intra-amniotic PGF2
RxNorm normalized name: amniotic fluid (bovine)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intra-amniotic PGF2 alpha combined with hypertonic saline, intravenous oxytocin, and a hygroscopic cervical dilator (Dilapan)
Trial: 29871023
Drug: Adjunctive homeopathy
RxNorm normalized name: Urtica urens homeopathic preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjunctive homeopathy
Trial: 27290985
Drug: RSGB group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RSGB group (lidocaine 1% 7 ml under ultrasound guidance)
Trial: 19222821
Drug: Rapid Diagnostic
RxNorm normalized name: Abreva Rapid Pain Relief
DrugBank: Glycerin (DB09462)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rapid Diagnostic Test (RDT) before treatment decision
Trial: 19222821
Drug: Clinical management
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clinical management (presumptive treatment)
Trial: 11593318
Drug: Bu/Mel/T (for
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bu/Mel/T (for patients with prior dose-limiting radiation)
Trial: 8106787
Drug: Chloroquine (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chloroquine (25 mg/kg over 48 h)
Trial: 8106787
Drug: Chloroquine plus
RxNorm normalized name: Chloroquine
DrugBank: Chloroquine (DB00608)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Chloroquine plus Clindamycin (5 mg/kg every 12 h for 6 doses)
Trial: 8106787
Drug: Quinine (12
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quinine (12 mg/kg every 12 h for 6 doses)
Trial: 8106787
Drug: Quinine plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quinine plus Clindamycin (5 mg/kg every 12 h for 6 doses)
Trial: 6228504
Drug: Preparation A
RxNorm normalized name: POVIDONE-IODINE 75 mg in 1 mL TOPICAL SOLUTION [Antiseptic Patient Preoperative Skin Preparation and Surgical Hand Scrub]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preparation A
Trial: 1139857
Drug: Commercial carbamazepine
RxNorm normalized name: Carbamazepine
DrugBank: Carbamazepine (DB00564)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Commercial carbamazepine tablets
Trial: 1139857
Drug: Propylene glycol
RxNorm normalized name: Propylene Glycol
DrugBank: Propylene glycol (DB01839)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Propylene glycol solution
Trial: 31118491
Drug: Low-dose helical
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose helical CT (LDCT) screening
Trial: 23601084
Drug: TM38837 500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TM38837 500 mg
Trial: 23601084
Drug: TM38837 100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TM38837 100 mg
Trial: 23601084
Drug: Rimonabant 60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rimonabant 60 mg
Trial: 9209174
Drug: Fish oil
RxNorm normalized name: Fish oil
DrugBank: Fish oil (DB13961)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fish oil (9 g/d)
Trial: 28922651
Drug: Bupropion +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bupropion + nicotine lozenge
Trial: 23674879
Drug: Medical adhesive
RxNorm normalized name: Medical Adhesive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medical adhesive spray (group A)
Trial: 11343664
Drug: Unfractionated heparin,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Unfractionated heparin, enoxaparin, or reviparin for at least 4 days, plus a coumarin derivative with a target INR of 2.0 to 3.0 starting on the 1st or 2nd day of treatment.
Trial: 1495357
Drug: Induction chemotherapy
RxNorm normalized name: human sputum, Bordetella pertussis infected
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Induction chemotherapy (cisplatin/5-FU) followed by definitive radiation (6600 to 7600 cGy)
Trial: 29797908
Drug: Governor vessel
RxNorm normalized name: acellular tissue engineered vessel Drug Implant [Symvess]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Governor vessel daoqi method of acupuncture combined with estazolam (2 mg, taken 30 min before sleeping)
Trial: 29797908
Drug: Estazolam alone
RxNorm normalized name: Estazolam
DrugBank: Estazolam (DB01215)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Estazolam alone (2 mg, taken 30 min before sleeping)
Trial: 17605483
Drug: External bleaching
RxNorm normalized name: CATHETER,EXTERNAL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: External bleaching treatment (bleaching gel for 60 minutes, followed by in-office bleaching and 2-week home bleaching for 1 hour daily)
Trial: 15843228
Drug: Stress doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Stress doses of hydrocortisone (100 mg loading dose followed by continuous infusion of 0.18 mg/kg/h for 6 days)
Trial: 9457193
Drug: Pulse-spray pharmacomechanical
RxNorm normalized name: dulse extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pulse-spray pharmacomechanical thrombolysis (PSPMT)
Trial: 7823364
Drug: Topical rhPDGF‐BB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical rhPDGF‐BB (2.2 micrograms/cm2 of ulcer area)
Trial: 7823364
Drug: Topical rhPDGF‐BB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical rhPDGF‐BB
Trial: 7823364
Drug: Topical rhPDGF‐BB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical rhPDGF‐BB and Placebo
Trial: 2248812
Drug: i.m. ketorolac
FDA approved: no
EMA approved: no
PMDA approved: no
Description: i.m. ketorolac trometamol 30 mg
Trial: 7309298
Drug: SROC 160
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SROC 160 (160 mg oxprenolol slow-release + 20 mg chlorthalidone once daily)
Trial: 7309298
Drug: COC 80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: COC 80 (80 mg oxprenolol + 10 mg chlorthalidone twice daily)
Trial: 30657033
Drug: C. spinosa
FDA approved: no
EMA approved: no
PMDA approved: no
Description: C. spinosa oxymel (10 mL/thrice daily for 3 months)
Trial: 24158337
Drug: Group IM
RxNorm normalized name: malarial plasmodium group immunoserum rabbit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group IM (immediately loaded implants)
Trial: 24158337
Drug: Group NL
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group NL (nonloaded implants)
Trial: 17989948
Drug: Hydrosome wound
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydrosome wound gel
Trial: 7834260
Drug: High-frequency electroconvulsive
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: High-frequency electroconvulsive therapy (ECT)
Trial: 28233128
Drug: 1210-nm laser
RxNorm normalized name: aminosalicylic acid
DrugBank: Aminosalicylic acid (DB00233)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 1210-nm laser treatment on one breast
Trial: 28233128
Drug: 1210-nm laser
RxNorm normalized name: aminosalicylic acid
DrugBank: Aminosalicylic acid (DB00233)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 1210-nm laser treatment
Trial: 22281786
Drug: Atorvastatin 10
RxNorm normalized name: atorvastatin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin 10 mg daily (Group A, 30 patients)
Trial: 22281786
Drug: Atorvastatin 10
RxNorm normalized name: atorvastatin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin 10 mg every other day (Group B, 30 patients)